Obvius Robotics

admin2522025-09-05 16:41:10

About Obvius Robotics

Founded in 2020 and headquartered in South Florida, USA, Obvius Robotics is a privately held medical device startup focused on developing handheld, image-guided robotic technologies for needle-based procedures such as central venous catheterization. The company's mission is to democratize vascular access, enabling clinicians of all experience levels to perform procedures with higher precision and reliability. Obvius Robotics also maintains clinical offices at the Center for Device Innovation at the Texas Medical Center in Houston, Texas.

Core Business & Flagship Products

Obvius Robotics revolutionizes vascular access with its flagship product, the CERTA™ Access System. This handheld robotic platform integrates ultrasound guidance with robotic needle placement and proprietary needle vibration technology, enhancing accuracy, safety, and procedural consistency. The CERTA™ Access System has demonstrated a 100% access success rate in initial clinical cases and received FDA Breakthrough Device Designation, underscoring its potential to improve patient care.

The technology addresses high complication rates in common procedures such as central line placements, offering expert-level precision at the push of a button.

Market Position & Strengths

Obvius Robotics occupies a strong position in the vascular access medical device market. The CERTA™ Access System represents a major innovation, providing unmatched precision and ease of use. The company completed its first U.S. clinical cases at leading institutions including Baylor St. Luke's Medical Center and Northwell Health. FDA submission is planned by the end of 2025, with U.S. approval anticipated in 2026.

Backed by a seasoned leadership team with expertise in medical device development and regulatory affairs, Obvius Robotics is well-positioned to drive innovation and improve clinical outcomes in vascular access procedures.